Abstract
Background
X-linked agammaglobulinemia, a primary immunodeficiency, can present with musculoskeletal manifestations.
Case characteristics
A 4-year-old boy, diagnosed as systemic juvenile idiopathic arthritis at the age of 3 years and treated with biological agents, presented with fever, dyspnea and chest pain. Blood culture and pericardial fluid culture revealed Achromobacter xylosoxidans.
Outcome
Investigation revealed normal serum ferritin but low levels of serum immunoglobulins. Further immunological work-up revealed diagnosis of X-linked agammaglobulinemia. Child improved on antibiotic therapy; treatment with steroids and biological was discontinued.
Message
Underlying immunodeficiency disease must be looked for in children suspected to have juvenile arthritis, more so if they develop unusual serious infection in response to immunomodulatory therapy.
Similar content being viewed by others
References
Winkelstein JA, Marino MC, Lederman HM, Jones SM, Sullivan K, Burks AW, et al. X-linked agammaglobulinemia: Report on a United States registry of 201 patients. Medicine. 2006; 85:193–202.
Hernandez-Trujillo VP, Scalchunes C, Cunningham-Rundles C, Ochs HD, Bonilla FA, Paris K, et al. Autoimmunity and Inflammation in X-linked Agammaglobulinemia. J Clin Immunol. 2014;34:627–32.
Gharib A, Gupta S. Skeletal and joint manifestations of primary immunodeficiency diseases. SOJ Immunol. 2016;4:1–13.
Hofer M, Southwood TR. Classification of childhood arthritis. Best Prac Res Clinic Rheumatol. 2002;16:379–96.
Ravelli A, Minoia F, Davy S, Horne AC, Bovis F, Pistorio A, et al. 2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Arthritis Rheumatol. 2016;68:566–76.
Igra-Siegman A, Chmel H, Cobbs C. Clinical and laboratory characteristics of achromobacter xylosoxidans infection. J Clin Microbiol. 1980;11:141–5.
Singh S, Rawat A, Suri D, Gupta A, Garg R, Saikia B, et al. X-linked agammaglobulinemia: Twenty years of singlecenter experience from North West India. Ann Allergy Asthma Immunol. 2016;4:405–11.
Sheehan WJ, Delmonte OM, Miller DT, Roberts AE, Bonilla FA, Morra M, et al. Novel presentation of Omenn syndrome in association with aniridia. J Allergy Clin Immunol. 2010;4: 967–8.
Weitkamp J-H, Tang Y-W, Haas DW, Midha NK, Crowe JE, Jr. Recurrent achromobacter xylosoxidans bacteremia associated with persistent lymph node infection in a patient with hyper-immunoglobulin M syndrome. Clin Infect Dis. 2000;31:1183–7.
Yokota S, Tanaka T, Kishimoto T. Efficacy, safety and tolerability of tocilizumab in patients with systemic juvenile idiopathic arthritis. Ther Adv Musculoskelet Dis. 2012;4:387–97.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Janarthanan, M., Gollapalli, S. & Sankaranarayanan, S. Achromobacter xylosoxidans Sepsis Unveiling X-linked Agammaglobulinemia Masquerading as Systemic-onset Juvenile Idiopathic Arthritis. Indian Pediatr 56, 423–425 (2019). https://doi.org/10.1007/s13312-019-1541-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-019-1541-3